Real-world evidence • Clinical • Next-generation sequencing • Circulating tumor DNA • Real-world • Metastases
|
EGFR (Epidermal growth factor receptor) • KRAS (KRAS proto-oncogene GTPase) • ALK (Anaplastic lymphoma kinase) • TP53 (Tumor protein P53) • PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • NRAS (Neuroblastoma RAS viral oncogene homolog) • PTEN (Phosphatase and tensin homolog) • IDH1 (Isocitrate dehydrogenase (NADP(+)) 1) • FGFR1 (Fibroblast growth factor receptor 1) • HRAS (Harvey rat sarcoma viral oncogene homolog) • CDKN2A (Cyclin Dependent Kinase Inhibitor 2A)
|
TP53 mutation • BRAF V600E • BRAF V600 • EGFR exon 19 deletion • KRAS G12D • EGFR amplification • KRAS G12V • FGFR1 amplification • ALK fusion • KRAS G12R • KRAS G12A • KRAS G12 • KRAS G13 • KRAS amplification • FGFR1 fusion • NRAS G12 • NRAS G13 • KRAS G13C • EGFR fusion • KRAS G61 • KRAS deletion
|
InVisionFirst®-Lung